|
ANP32E expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.130200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.809000E-01 |
| Normal-vs-Stage2 |
5.779400E-01 |
| Normal-vs-Stage3 |
2.755600E-01 |
| Normal-vs-Stage4 |
1.431150E-01 |
| Stage1-vs-Stage2 |
3.592600E-01 |
| Stage1-vs-Stage3 |
3.800800E-01 |
| Stage1-vs-Stage4 |
1.360600E-01 |
| Stage2-vs-Stage3 |
1.505810E-01 |
| Stage2-vs-Stage4 |
8.648000E-02 |
| Stage3-vs-Stage4 |
4.485400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.930400E-01 |
| Normal-vs-AfricanAmerican |
7.073700E-02 |
| Normal-vs-Asian |
7.027800E-01 |
| Caucasian-vs-AfricanAmerican |
9.526100E-02 |
| Caucasian-vs-Asian |
9.922000E-01 |
| AfricanAmerican-vs-Asian |
1.153030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.472400E-01 |
| Normal-vs-Female |
3.466000E-01 |
| Male-vs-Female |
5.506200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.370000E-01 |
| Normal-vs-Age(41-60Yrs) |
8.478400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.106000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.410200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.159200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.036200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.090000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.053200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.995400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.809800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.057200E-01 |
| Classical-VS-Follicular |
4.257900E-03 |
| Classical-VS-Other |
4.229400E-01 |
| Classical-VS-Normal |
8.034200E-02 |
| Tall-VS-Follicular |
1.993960E-01 |
| Tall-VS-Other |
5.587600E-01 |
| Tall-VS-Normal |
5.287000E-01 |
| Follicular-VS-Other |
8.805200E-01 |
| Follicular-VS-Normal |
3.406800E-01 |
| Other-VS-Normal |
7.674400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.148400E-01 |
| Normal-vs-N1 |
4.903200E-01 |
| N0-vs-N1 |
2.552800E-01 |
|
|
